**Core Concept**
Suxamethonium, also known as succinylcholine, is a depolarizing neuromuscular blocking agent used in anesthesia to facilitate endotracheal intubation and provide muscle relaxation during surgery.

**Why the Correct Answer is Right**
Suxamethonium acts by mimicking the action of acetylcholine at the neuromuscular junction, causing initial depolarization of the muscle fibers. This leads to a prolonged depolarization, resulting in muscle paralysis. The enzyme acetylcholinesterase is responsible for breaking down acetylcholine, but in the case of suxamethonium, it is not broken down efficiently, prolonging its action.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because suxamethonium is not a non-depolarizing neuromuscular blocker, which acts by competitively blocking acetylcholine receptors at the neuromuscular junction.
**Option B:** This option is incorrect because suxamethonium is not a benzodiazepine, which is a class of sedatives used for anesthesia and muscle relaxation.
**Option C:** This option is incorrect because suxamethonium is not a volatile anesthetic, which is a class of inhalational anesthetics used to induce and maintain general anesthesia.

**Clinical Pearl / High-Yield Fact**
Suxamethonium can cause a significant increase in serum potassium levels due to the release of potassium from muscle cells during depolarization, which can be a concern in patients with pre-existing hyperkalemia or renal impairment.

**Correct Answer: A. Suxamethonium is a depolarizing neuromuscular blocker.**